These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17129905)

  • 1. Adherence to HAART: perspectives from clients in treatment support programs.
    Weiss L; French T; Waters M; Netherland J; Agins B; Finkelstein R
    Psychol Health Med; 2006 May; 11(2):155-70. PubMed ID: 17129905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-related knowledge and adherence to HAART.
    Weiss L; French T; Finkelstein R; Waters M; Mukherjee R; Agins B
    AIDS Care; 2003 Oct; 15(5):673-9. PubMed ID: 12959818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview and implementation of an intervention to prevent adherence failure among HIV-infected adults initiating antiretroviral therapy: lessons learned from Project HEART.
    Davies G; Koenig LJ; Stratford D; Palmore M; Bush T; Golde M; Malatino E; Todd-Turner M; Ellerbrock TV
    AIDS Care; 2006 Nov; 18(8):895-903. PubMed ID: 17012078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participatory evaluation of counselling, medical and social services of The AIDS Support Organization (TASO) in Uganda.
    Kaleeba N; Kalibala S; Kaseje M; Ssebbanja P; Anderson S; van Praag E; Tembo G; Katabira E
    AIDS Care; 1997 Feb; 9(1):13-26. PubMed ID: 9155910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.
    Stone VE
    Clin Infect Dis; 2001 Sep; 33(6):865-72. PubMed ID: 11512092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating adherence to highly active antiretroviral therapy into children's daily lives: a qualitative study.
    Hammami N; Nöstlinger C; Hoerée T; Lefèvre P; Jonckheer T; Kolsteren P
    Pediatrics; 2004 Nov; 114(5):e591-7. PubMed ID: 15520091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment adherence to an antiretroviral regime: the lived experience of Native Hawaiians and kokua.
    Ka'opua L
    Pac Health Dialog; 2001 Sep; 8(2):290-8. PubMed ID: 12180508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia.
    Tadios Y; Davey G
    Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An information-motivation-behavioral skills model of adherence to antiretroviral therapy.
    Fisher JD; Fisher WA; Amico KR; Harman JJ
    Health Psychol; 2006 Jul; 25(4):462-73. PubMed ID: 16846321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative therapy use in HIV-infected patients receiving highly active antiretroviral therapy.
    Risa KJ; Nepon L; Justis JC; Panwalker A; Berman SM; Cinti S; Wagener MM; Singh N
    Int J STD AIDS; 2002 Oct; 13(10):706-13. PubMed ID: 12396542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging the gap between antiretroviral access and adherence in Mexico.
    Campero L; Herrera C; Kendall T; Caballero M
    Qual Health Res; 2007 May; 17(5):599-611. PubMed ID: 17478643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social support and adherence: differences among clients in an AIDS day health care program.
    Gardenier D; Andrews CM; Thomas DC; Bookhardt-Murray LJ; Fitzpatrick JJ
    J Assoc Nurses AIDS Care; 2010; 21(1):75-85. PubMed ID: 19819169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained antiretroviral treatment adherence in survivors of the pre-HAART era: attitudes and beliefs.
    Fumaz CR; Muñoz-Moreno JA; Moltó J; Ferrer MJ; López-Blázquez R; Negredo E; Paredes R; Gómez G; Clotet B
    AIDS Care; 2008 Aug; 20(7):796-805. PubMed ID: 18728987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy.
    Luszczynska A; Sarkar Y; Knoll N
    Patient Educ Couns; 2007 Apr; 66(1):37-42. PubMed ID: 17097259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shaping garments of care: tools for maximizing adherence potential.
    Boyer A; Indyk D
    Soc Work Health Care; 2006; 42(3-4):151-66. PubMed ID: 16687380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.